Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi STOXX Europe 600 Healthcare UCITS ETF Dist
EHLT · LU2082997516 · class UCITS ETF Dist · EUR · domicile Luxembourg
Equity · Europe · Health careSFDR art. 6
Index tracked: STOXX Europe 600 Health Care Net Return EUR
- TER
- 0.30%+ trans. 0.00%
- Fund size
- 70 m EUR
- Tracking difference
- −0.26%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Distributingannual
Launch 21 Mar 2024 · costs from the KID as of 2 Sept 2026 · 49 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of STOXX Europe 600 Health Care Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index: dividends net of tax paid by the Index constituents are included in the Index return. The Index is a market cap weighted index designed…
Performance since series start (in euro) — base 100
2 Jul 2020 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +5.1% |
| 3 years | +6.2% |
| 5 years | +14.6% |
| 10 years | series too young |
| Since series start | +29.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 16.75% | 15.96% | 15.48% |
| Max drawdown | −12.47% | −27.60% | −27.60% |
| Sharpe | 0.20 | -0.09 | 0.02 |
| Sortino | 0.30 | -0.12 | 0.02 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EHLT · LU20829975161
RebalixEHLT · LU2082997516 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +6.38% | +6.64% | −0.26% |
| 2024 | +4.26% | +4.57% | −0.31% |
| 2023 | +8.16% | +8.38% | −0.22% |
| 2022 | −6.27% | −6.21% | −0.07% |
| 2021 | +25.39% | +25.51% | −0.12% |
Distributions · per share, in EUR
Frequency: annual · last 12 months: 2.50 EUR (1.33% of NAV) · last ex-date 9 Dec 2025
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 2.50 | +1.37% |
| 2024 | 1 | 3.24 | +1.82% |
| 2023 | 1 | 2.91 | +1.74% |
| 2022 | 2 | 3.86 | +2.11% |
| 2021 | 2 | 3.43 | +2.31% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 49 securities · top-10 weight = 56.3%
| Top holdings | Weight |
|---|---|
| 8.9% | |
| 8.4% | |
| 6.9% | |
| 6.7% | |
| 4.8% | |
| 4.5% | |
| 4.2% | |
| 4.1% | |
| 4.1% | |
| 3.8% |
Listing venues
ESMA register (FIRDS) and official exchange lists
EHLT · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 15 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2082997516
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2082997516
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · EHLT · LU20829975162